Evaluation of direct-to-consumer low-volume lab tests in healthy adults.

BACKGROUND Clinical laboratory tests are now being prescribed and made directly available to consumers through retail outlets in the USA. Concerns with these test have been raised regarding the uncertainty of testing methods used in these venues and a lack of open, scientific validation of the technical accuracy and clinical equivalency of results obtained through these services. METHODS We conducted a cohort study of 60 healthy adults to compare the uncertainty and accuracy in 22 common clinical lab tests between one company offering blood tests obtained from finger prick (Theranos) and 2 major clinical testing services that require standard venipuncture draws (Quest and LabCorp). Samples were collected in Phoenix, Arizona, at an ambulatory clinic and at retail outlets with point-of-care services. RESULTS Theranos flagged tests outside their normal range 1.6× more often than other testing services (P < 0.0001). Of the 22 lab measurements evaluated, 15 (68%) showed significant interservice variability (P < 0.002). We found nonequivalent lipid panel test results between Theranos and other clinical services. Variability in testing services, sample collection times, and subjects markedly influenced lab results. CONCLUSION While laboratory practice standards exist to control this variability, the disparities between testing services we observed could potentially alter clinical interpretation and health care utilization. Greater transparency and evaluation of testing technologies would increase their utility in personalized health management. FUNDING This work was supported by the Icahn Institute for Genomics and Multiscale Biology, a gift from the Harris Family Charitable Foundation (to J.T. Dudley), and grants from the NIH (R01 DK098242 and U54 CA189201, to J.T. Dudley, and R01 AG046170 and U01 AI111598, to E.E. Schadt).

[1]  A. Díez-Noguera,et al.  Circadian rhythmic variations in serum concentrations of clinically important lipids. , 1994, Clinical chemistry.

[2]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[3]  C. Price Roots, development and future directions of laboratory medicine , 2010, Clinical chemistry and laboratory medicine.

[4]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[5]  Søren Højsgaard,et al.  A Kenward-Roger approximation and parametric bootstrap methods for tests in linear mixed models: The R Package pbkrtest , 2014 .

[6]  A. Horvath,et al.  From evidence to best practice in laboratory medicine. , 2013, The Clinical biochemist. Reviews.

[7]  Hhs Office for Civil Rights,et al.  CLIA program and HIPAA privacy rule; patients' access to test reports. Final rule. , 2014, Federal register.

[8]  J. Mckenney,et al.  National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary. , 2014, Journal of clinical lipidology.

[9]  R. Green,et al.  Consumers report lower confidence in their genetics knowledge following direct-to-consumer personal genomic testing , 2015, Genetics in Medicine.

[10]  M. C. Jones,et al.  A reliable data-based bandwidth selection method for kernel density estimation , 1991 .

[11]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[12]  N. Schork,et al.  Effect of direct-to-consumer genomewide profiling to assess disease risk. , 2011, The New England journal of medicine.

[13]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[14]  S. J. Smith,et al.  A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements. , 2000, Clinical chemistry.

[15]  R. Sothern,et al.  Reference values for circadian rhythms of 98 variables in clinically healthy men in the fifth decade of life. , 1990, Chronobiology international.

[16]  John P A Ioannidis,et al.  Stealth research: is biomedical innovation happening outside the peer-reviewed literature? , 2015, JAMA.

[17]  A. Díez-Noguera,et al.  Circadian rhythms of serum concentrations of 12 enzymes of clinical interest. , 1993, Chronobiology international.

[18]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.